Scarica l'app Stockscreener
64.70
2.45%
1.50
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GEHC Giù?
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$63.20
Aprire:
$63.19
Volume 24 ore:
1.29M
Relative Volume:
0.25
Capitalizzazione di mercato:
$29.45B
Reddito:
$20.98B
Utile/perdita netta:
$1.98B
Rapporto P/E:
15.49
EPS:
4.177
Flusso di cassa netto:
$1.52B
1 W Prestazione:
+0.07%
1M Prestazione:
+2.40%
6M Prestazione:
-20.80%
1 anno Prestazione:
-14.19%
Intervallo 1D:
$63.18
$64.82
Intervallo di 1 settimana:
$60.53
$66.06
Portata 52W:
$58.75
$89.77
Ge Healthcare Technologies Inc Stock (GEHC) Company Profile
Nome
Ge Healthcare Technologies Inc
Settore
Industria
Telefono
833-735-1139
Indirizzo
500 WEST MONROE STREET, CHICAGO
Compare GEHC vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GEHC
Ge Healthcare Technologies Inc
|
64.73 | 28.75B | 20.98B | 1.98B | 1.52B | 4.177 |
ABT
Abbott Laboratories
|
100.14 | 155.49B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
333.79 | 121.31B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
84.09 | 103.01B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
45.05 | 63.97B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
88.39 | 50.25B | 6.30B | 1.07B | 1.09B | 1.8406 |
Ge Healthcare Technologies Inc Stock (GEHC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-15 | Downgrade | UBS | Neutral → Sell |
| 2025-10-13 | Iniziato | Barclays | Equal Weight |
| 2025-10-07 | Downgrade | Citigroup | Buy → Neutral |
| 2025-05-05 | Aggiornamento | UBS | Sell → Neutral |
| 2025-03-11 | Aggiornamento | Goldman | Neutral → Buy |
| 2025-01-08 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-09-26 | Downgrade | UBS | Neutral → Sell |
| 2024-09-18 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2024-09-09 | Iniziato | JP Morgan | Neutral |
| 2024-08-06 | Iniziato | Stifel | Buy |
| 2024-05-30 | Iniziato | Goldman | Neutral |
| 2024-02-15 | Iniziato | HSBC Securities | Buy |
| 2024-02-12 | Aggiornamento | UBS | Sell → Neutral |
| 2023-11-30 | Iniziato | Jefferies | Hold |
| 2023-11-27 | Downgrade | UBS | Neutral → Sell |
| 2023-09-19 | Iniziato | Citigroup | Buy |
| 2023-08-25 | Iniziato | Argus | Buy |
| 2023-08-16 | Iniziato | Wells Fargo | Overweight |
| 2023-07-31 | Iniziato | BofA Securities | Neutral |
| 2023-06-27 | Iniziato | Morgan Stanley | Equal-Weight |
| 2023-05-16 | Iniziato | Oppenheimer | Outperform |
| 2023-04-26 | Iniziato | UBS | Neutral |
| 2023-04-19 | Iniziato | Piper Sandler | Overweight |
| 2023-04-10 | Iniziato | BTIG Research | Neutral |
| 2023-03-13 | Iniziato | Evercore ISI | Outperform |
| 2023-02-17 | Iniziato | Mizuho | Buy |
| 2023-01-19 | Iniziato | Redburn | Buy |
Mostra tutto
Ge Healthcare Technologies Inc Borsa (GEHC) Ultime notizie
UBS Adjusts Price Target on GE Healthcare Technologies to $67 From $69, Maintains Neutral Rating - marketscreener.com
GE HealthCare (GEHC) Lands $500 Million Catholic Health Deal For Imaging And AI - Yahoo Finance UK
Catholic Health and GE HealthCare partner to expand patient access across Long Island - mykxlg.com
GE HealthCare (GEHC) Stock Trades Below Fair Value On Cash Flow And Earnings - simplywall.st
GE HealthCare Technologies (GEHC) Following Mayo Clinic Trial Tie Up Faces A Fresh Valuation Test - Yahoo Finance
GE HealthCare Technologies Inc. stock rises Wednesday, outperforms market - MarketWatch
Can GE HealthCare (GEHC) Turn Theranostic Partnerships Into a Durable Advanced Diagnostics Edge? - Yahoo Finance
Analysts Conflicted on These Healthcare Names: Irhythm Technologies (IRTC), Penumbra (PEN) and Evolus (EOLS) - The Globe and Mail
RBC Capital Keeps Their Buy Rating on GE Healthcare Technologies Inc (GEHC) - The Globe and Mail
GE HealthCare Technologies Inc.'s Stock Price Dips to $61.66, Recording a Significant 5.59% Drop - Smartkarma
GE HealthCare Technologies Inc. (NASDAQ:GEHC) sheds $1.7 billion as HCA warning tests order-growth case - TechStock²
GE HealthCare Technologies Inc. stock falls Tuesday, underperforms market - MSN
US36266GAB3 Bond Profile — Key Metrics - TradingView
Why GE HealthCare Technologies (GEHC) Stock Is Down Today - Quiver Quantitative
Do Options Traders Know Something About GE HealthCare Stock We Don't? - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Medtronic (MDT), Quest Diagnostics (DGX) and Gilead Sciences (GILD) - The Globe and Mail
Is GE HealthCare stock underperforming the S&P 500? - MSN
BTIG Research Adjusts GE Healthcare Technologies Price Target to $75 From $80, Maintains Buy Rating - Moomoo
BTIG Maintains GE HealthCare Technologies(GEHC.US) With Buy Rating, Cuts Target Price to $75 - Moomoo
Is GE HealthCare Technologies (GEHC) A Bargain On Its Mayo Clinic MI BET Study News? - Sahm
Wells Fargo Maintains GE HealthCare Technologies (GEHC) Overweight Recommendation - MSN
GE HealthCare wins FDA 510(k) clearance for Photonova Spectra PCCT - MSN
BMO Capital Initiates GE HealthCare Technologies(GEHC.US) With Hold Rating, Announces Target Price $70 - Moomoo
Securities Fraud Investigation Into GE HealthCare Technologies In - The National Law Review
GE HealthCare expands mammography collaboration with RadNet’s Dee - The National Law Review
GE HealthCare stock stays supported by imaging demand - ad-hoc-news.de
Healthcare: Stocks Had a Mixed Q2, but Defensive Nature and Innovation Look Attractive - Morningstar
GE HealthCare & Mayo Clinic Unite to Advance Cancer Theranostics - The Globe and Mail
GE HealthCare extends imaging reach as US diagnostics demand grows - ad-hoc-news.de
Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) ContinuesShareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm - TradingView
Jefferies Maintains GE HealthCare Technologies(GEHC.US) With Buy Rating, Cuts Target Price to $90 - Moomoo
GE Healthcare and Mayo Clinic Aim to Advance Personalized Cancer Treatment Through New Theranostics Research Collaboration | Newswise - Newswise
Citigroup Adjusts GE Healthcare Technologies Price Target to $69 From $65 - Moomoo
GE HealthCare explores growth in medical imaging and diagnostics - AD HOC NEWS
GE HealthCare and Mayo Clinic launch prostate cancer study By Investing.com - Investing.com Canada
GE HealthCare and Mayo Clinic test personalized cancer therapy for prostate tumors - Stock Titan
GE HealthCare and Mayo Clinic aim to advance personalized cancer treatment through new theranostics research collaboration - Mayo Clinic News Network
GE HealthCare Technologies Inc. (GEHC) Shareholders Who Lost MoneyContact Law Offices of Howard G. Smith About Securities Fraud Investigation - TradingView
Citi Maintains GE HealthCare Technologies(GEHC.US) With Hold Rating, Maintains Target Price $69 - Moomoo
GE HealthCare Q2 results due July 29, with call and webcast - Stock Titan
Press Release: GE HealthCare to Announce Second Quarter 2026 Results on July 29, 2026 - Moomoo
GE HealthCare to announce second quarter 2026 results on July 29, 2026 - marketscreener.com
AI, Cybersecurity, and Interoperable Systems: Core Pillars Driving the Smart Hospital Evolution - GlobeNewswire Inc.
GE HealthCare faces investigation after Q1 earnings miss and share price drop due to supplier recall issues. - Pluang
Earnings preview: What to expect from GE HealthCare Technologies’ report - MSN
GE HealthCare outlines its imaging strategy as investors track US-listed shares - AD HOC NEWS
GE HealthCare Technologies Inc. stock falls Monday, underperforms market - MarketWatch
GE HealthCare (GEHC) Introduces AI-Driven Upgrade Pathways to Modernize Legacy Imaging Suites - Insider Monkey
Ge healthcare director Stromberg buys $61,689 stock - Investing.com
How GE HealthCare’s Retrofit-Focused Allia Upgrades At GE HealthCare Technologies (GEHC) Has Changed Its Investment Story - Sahm
GE HealthCare Technologies declares $0.035 dividend - MSN
Ge Healthcare Technologies Inc Azioni (GEHC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Ge Healthcare Technologies Inc Azioni (GEHC) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Hochman Rodney F | Director |
May 12 '26 |
Buy |
62.03 |
1,618 |
100,365 |
1,618 |
| Yang Watkin Phoebe L. | Director |
May 08 '26 |
Buy |
63.01 |
1,000 |
63,006 |
13,702 |
| CULP H LAWRENCE JR | Director |
May 06 '26 |
Buy |
61.88 |
80,805 |
5,000,076 |
151,207 |
| Stromberg William J | Director |
May 06 '26 |
Buy |
61.69 |
1,000 |
61,689 |
15,330 |
| SACCARO JAMES | Chief Financial Officer |
May 01 '26 |
Buy |
60.60 |
3,310 |
200,585 |
87,471 |
| Jimenez Frank R | GC & Corporate Secretary |
Apr 30 '26 |
Buy |
60.45 |
1,750 |
105,788 |
93,932 |
| Arduini Peter J | President and CEO |
Apr 30 '26 |
Buy |
59.92 |
4,169 |
249,827 |
259,424 |
3.25%
0.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):